Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Jun 2024 for Biora Therapeutics, INC.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Brian L. Kotzin: trading record in brief
Filings by Brian L. Kotzin span 2 companies, the busiest being Biora Therapeutics, Inc. and Rigel Pharmaceuticals Inc. In total, 9 filings cover trades dated from 19 May 2021 to 5 June 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 6 June 2024 with a share grant in Biora Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Brian L. Kotzin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
12,500 shares0Common StockSEC:0000950170-24-069927:0
25,000 shares0Common StockSEC:0000905148-24-001653:0
25,000 shares0Common StockSEC:0001140361-23-034283:0
12,500 shares0Common StockSEC:0000950170-23-028599:0
44 sharesSeries X Preferred StockSEC:0000899243-23-000970:0
96,154 shares0Common StockSEC:0000899243-22-023092:0
25,000 shares0Common StockSEC:0001140361-22-020302:0
29,183 shares0Common StockSEC:0000899243-21-024206:0
25,000 shares0Common StockSEC:0001179110-21-005768:0
9 of 9 declarations
